findmyKOL
Clinical trialNCT01774097CompletedPhase 2Interventional

Patients With Intermittent Claudication Injected With ALDH Bright Cells

SponsorThe University of Texas Health Science Center, HoustonEnrollment82Intermittent ClaudicationPeripheral Artery Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find out if aldehyde dehydrogenase bright (ALDHbr) cells taken from a patient's bone marrow can be placed safely, via intramuscular injections, into their affected calf and lower thigh muscles and improve blood flow and/or peak walking time in patients experiencing pain associated with blocked blood vessels in the leg.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University School of Medicine (falk Cardiovascular Research Center)

    Stanford, California, United States

  • University of Florida-Department of Medicine

    Gainesville, Florida, United States

  • University of Miami-Interdisciplinary Stem Cell Institute

    Miami, Florida, United States

  • Orlando Health Inc.

    Orlando, Florida, United States

  • Indiana Center for Vascular Biology and Medicine

    Indianapolis, Indiana, United States

  • University of Louisville

    Louisville, Kentucky, United States

  • Clinical and Translational Science Institute at University of Minnesota

    Minneapolis, Minnesota, United States

  • Minneapolis Heart Institute Foundation

    Minneapolis, Minnesota, United States

  • Texas Heart Institute

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ALD-301Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2013
Primary completion
31 Aug 2016
Completion
31 Mar 2017
Last update posted
21 Apr 2017
Registered enrollment
82
Registry id
NCT01774097
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.